The engineering better ageing market is primarily driven by the growing ageing population and the increasing prevalence of age-related diseases, coupled with advancements in regenerative medicine. However, market expansion is restrained by the potential risks associated with ageing treatments. Conversely, the integration of omics data into diagnostic tools and medical devices is expec... https://www.nextmsc.com/report/engineering-better-ageing-market-hc3191